| |
| |
|
| Insider
Information: |
Cole G Bradley |
| Relationship: |
|
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
73,857 |
|
|
Indirect Shares
|
12,334 |
|
|
| Direct
Value |
$3,432,528 |
|
|
|
Indirect Value
|
$558,114 |
|
|
| Total
Shares |
86,191 |
|
|
| Total
Value |
$3,990,642 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genomic Health Inc |
GHDX |
CFO |
2018-10-10 |
45,372 |
2019-11-08 |
0 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
General Manager - Diag... |
2020-02-19 |
10,194 |
2020-01-16 |
12,334 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2022-06-10 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2023-06-29 |
5,000 |
2023-06-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
255 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GHDX |
Genomic Health Inc |
COO |
• – – |
2018-09-11 |
4 |
AS |
$63.87 |
$320,074 |
D/D |
(5,000) |
45,372 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2018-10-10 |
4 |
OE |
$17.18 |
$85,900 |
D/D |
5,000 |
50,372 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2018-10-10 |
4 |
AS |
$62.77 |
$315,955 |
D/D |
(5,000) |
45,372 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-06-11 |
4 |
OE |
$17.18 |
$85,900 |
I/I |
5,000 |
48,722 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-06-11 |
4 |
AS |
$51.30 |
$257,281 |
I/I |
(5,000) |
43,722 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-08-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
38,970 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
|
– • – |
2023-06-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2017-03-08 |
4 |
OE |
$23.31 |
$130,769 |
D/D |
5,610 |
45,338 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2017-03-08 |
4 |
AS |
$29.83 |
$180,134 |
D/D |
(5,710) |
39,528 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2013-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
19,135 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2015-09-08 |
4 |
AS |
$25.32 |
$151,929 |
D/D |
(6,000) |
30,326 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2015-09-08 |
4 |
OE |
$9.39 |
$56,340 |
D/D |
6,000 |
36,326 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2014-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,420 |
24,789 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-07-09 |
4 |
OE |
$17.18 |
$111,172 |
I/I |
6,471 |
50,441 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
CFO |
• – – |
2019-07-09 |
4 |
AS |
$56.23 |
$369,386 |
I/I |
(6,471) |
43,970 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2012-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,700 |
14,450 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2011-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,750 |
7,750 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2018-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
7,590 |
47,936 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2017-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8,140 |
44,022 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2016-10-10 |
4 |
OE |
$18.89 |
$175,560 |
D/D |
8,290 |
39,716 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2016-10-10 |
4 |
AS |
$30.51 |
$253,572 |
D/D |
(8,290) |
35,426 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2018-08-09 |
4 |
OE |
$17.18 |
$146,528 |
D/D |
8,529 |
53,901 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
COO |
• – – |
2018-08-09 |
4 |
AS |
$55.51 |
$477,105 |
D/D |
(8,529) |
45,372 |
0 |
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2024-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,636 |
13,291 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
EVP & CFO |
• – – |
2008-02-19 |
4 |
AS |
$22.57 |
$203,246 |
D/D |
(9,000) |
8,298 |
0 |
- |
|
255 Records found
|
|
Page 9 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
